Close Menu

The GET conference is underway in Cambridge and James Watson, one of the "personal genome pioneers" at the meeting, is letting his thoughts be known during the discussions. At this time in his life, Watson says he wasn't worried about what he might have learned from getting his genome sequenced. "If I were 20 I wouldn't want to know because you just worry. At 80 I don't worry if I'm going to get cancer," Watson said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.